These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
3. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy]. Glanzmann C; Lütolf UM Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505 [TBL] [Abstract][Full Text] [Related]
4. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic]. Mjaaland I; Ganser D; Freitag EM; Bohndorf W Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173 [TBL] [Abstract][Full Text] [Related]
5. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions]. Glanzmann C; Lütolf UM Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981 [TBL] [Abstract][Full Text] [Related]
6. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060 [TBL] [Abstract][Full Text] [Related]
7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [TBL] [Abstract][Full Text] [Related]
8. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333 [TBL] [Abstract][Full Text] [Related]
9. Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease. Cosset JM; Fermé C; Noordijk EM; Dubray BM; Thirion P; Henry-Amar M Semin Radiat Oncol; 1996 Jul; 6(3):185-195. PubMed ID: 10717177 [TBL] [Abstract][Full Text] [Related]
10. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. Hudson MM; Krasin M; Link MP; Donaldson SS; Billups C; Merchant TE; Kun L; Billet AL; Kaste S; Tarbell NJ; Howard S; Friedmann AM; Hurwitz CA; Young JA; Marcus KC; Rai S; Cowan T; Weinstein HJ J Clin Oncol; 2004 Nov; 22(22):4541-50. PubMed ID: 15542805 [TBL] [Abstract][Full Text] [Related]
11. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
12. [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults]. Glanzmann C; Stahel R Praxis (Bern 1994); 1995 Oct; 84(41):1140-7. PubMed ID: 7481323 [TBL] [Abstract][Full Text] [Related]
14. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650 [TBL] [Abstract][Full Text] [Related]
15. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092 [TBL] [Abstract][Full Text] [Related]
16. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452 [TBL] [Abstract][Full Text] [Related]
17. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B; Bode U; von Schweinitz D Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease. Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201 [TBL] [Abstract][Full Text] [Related]
19. Septicemia and meningitis in children splenectomized for hodgkin's disease. Chilcote RR; Baehner RL; Hammond D N Engl J Med; 1976 Oct; 295(15):798-800. PubMed ID: 958275 [TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease: multidisciplinary contributions to the conquest of a neoplasm. Erskine memorial lecture, 1976. Kaplan HS Radiology; 1977 Jun; 123(3):551-8. PubMed ID: 404663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]